Recombinant Sars-Cov-2 (COVID-19/2019-nCov) Spike RBD Protein
Fig 1 : Recombinant 2019-nCoV Spike RBD Protein was determined by SDS-PAGE with Coomassie Blue, showing a band at 36 kDa.
Roll over image to zoom in
Shipping Info:
For estimated delivery dates, please contact us at [email protected]
| Amount : | 100 µg |
| Purification : | >95% by SDS-PAGE. |
| Content : | Lyophilized from a 0.22 µm filtered solution of PBS, pH 7.4. |
| Storage condition : | Store the lyophilized protein at -20°C to -80 °C for long term. After reconstitution, the protein solution is stable at -20 °C for 3 months, at 2-8 °C for up to 1 week. |
| AA sequence : | Tag Fc, 6×His tag at the C-terminus.(Arg319-Phe541) |
| Gene ID : | 43740568 |
| Alternative Name : | S1-RBD protein,NCP-CoV RBD Protein,novel coronavirus RBD Protein,2019-nCoV RBD Protein,S glycoprotein Subunit1 RBD Protein, SARS |
Source: HEK293 cells.
Endotoxin: < 0.1 EU/µg of the protein by LAL method.
Recombinant 2019-nCoV Spike RBD-His Protein is produced by HEK293 cells expression system. The target protein is expressed with sequence (Arg319-Phe541) of 2019-ncov Spike RBD-His (Accession #YP_009724390.1) fused with an 6×His tag at the C-terminus.
Reconstitute to a concentration of 0.1-0.5 mg/mL in sterile distilled water.
For Research Use Only. Not for use in diagnostic/therapeutics procedures.
Doan C. Nguyen1, Ian T. Hentenaar1, Andrea Morrison-Porter1, David Solano1, Natalie S.Haddad1, Carlos Castrillon2, Pedro A. Lamothe1, Joel Andrews3, Danielle Roberts3, SagarLonial3, Ignacio Sanz2,4, F. Eun-Hyung Lee1,4*
The Majority of SARS-CoV-2 Plasma Cells are Excluded from the Bone Marrow LongLived Compartment 33 Months after mRNA Vaccination
medRxiv preprint doi: https://doi.org/10.1101/2024.03.02.24303242; this version posted March 5, 2024.
https://www.medrxiv.org/content/10.1101/2024.03.02.24303242v1.full.pdf
|
There are currently no product reviews
|
.png "ACE2/HEK293 Stable Cell Line")
